Pacer Advisors
USNA icon

Pacer Advisors’s Usana Health Sciences USNA Stock Holding History

Pacer Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38
Closed -$1.05K – 3868
2025
Q3 		$1.05K Sell
38
-92,478
-100% -$2.85M ﹤0.01% 3834
2025
Q2 		$2.82M Sell
92,516
-34,978
-27% -$993K 0.01% 898
2025
Q1 		$3.44M Sell
127,494
-464,507
-78% -$14.7M 0.01% 781
2024
Q4 		$21.2M Buy
592,001
+47,745
+9% +$1.79M 0.05% 326
2024
Q3 		$20.6M Buy
544,256
+76,904
+16% +$3.16M 0.04% 327
2024
Q2 		$21.1M Buy
467,352
+58,597
+14% +$2.7M 0.05% 311
2024
Q1 		$19.8M Buy
408,755
+71,384
+21% +$3.5M 0.05% 322
2023
Q4 		$18.1M Buy
337,371
+145,373
+76% +$7.35M 0.05% 311
2023
Q3 		$11.3M Buy
191,998
+59,736
+45% +$3.74M 0.04% 308
2023
Q2 		$8.34M Sell
132,262
-3,071
-2% -$196K 0.03% 432
2023
Q1 		$8.51M Buy
135,333
+37,214
+38% +$2.22M 0.04% 452
2022
Q4 		$5.22M Buy
98,119
+33,496
+52% +$1.81M 0.03% 426
2022
Q3 		$3.62M Sell
64,623
-747
-1% -$49.4K 0.03% 387
2022
Q2 		$4.73M Buy
65,370
+16,084
+33% +$1.2M 0.04% 372
2022
Q1 		$3.92M Buy
49,286
+9,522
+24% +$858K 0.03% 469
2021
Q4 		$4.02M Buy
39,764
+8,603
+28% +$858K 0.04% 542
2021
Q3 		$2.87M Buy
+31,161
New +$3M 0.04% 589
2021
Q2 		– Sell
-15,899
Closed -$1.55M – 1560
2021
Q1 		$1.55M Buy
15,899
+10,408
+190% +$947K 0.03% 595
2020
Q4 		$423K Buy
5,491
+1,909
+53% +$148K 0.01% 1035
2020
Q3 		$264K Buy
3,582
+937
+35% +$75.2K 0.01% 1143
2020
Q2 		$194K Buy
2,645
+531
+25% +$41.7K ﹤0.01% 807
2020
Q1 		$145K Sell
2,114
-2,450
-54% -$170K ﹤0.01% 466
2019
Q4 		$359K Sell
4,564
-1,379
-23% -$102K 0.02% 858
2019
Q3 		$406K Buy
+5,943
New +$399K 0.01% 1030

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors's USNA Position: Q4 2025 in Review

Pacer Advisors sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 38 shares — an estimated $1.05K sold.

Pacer Advisors first reported a position in USNA in Q3 2019 and held it in 24 quarters. The position peaked at $21.2M in Q4 2024. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Pacer Advisors reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Pacer Advisors sold 38 Usana Health Sciences shares in Q4 2025, an estimated $1.05K.
  • Pacer Advisors first reported a position in Usana Health Sciences in Q3 2019 and held it in 24 quarters.
  • Pacer Advisors's Usana Health Sciences position peaked at $21.2M in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Pacer Advisors's 13F filing for Q4 2025, filed 4 Feb 2026.